Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the fourth quarter and fiscal year 2025. Following the completion of the sale of INBRX-101 ...

The rapid and unchecked pursuit of new technologies must not come at the expense of our national parks, which were set aside ...

Zura Bio Limited (Nasdaq: ZURA) ("Zura"), a clinical‑stage biotechnology company developing novel and differentiated ...

SACRAMENTO, CA, UNITED STATES, March 19, 2026 /EINPresswire.com/ — California State Treasurer Fiona Ma today announced the latest results of California’s public financial savings programs, setting new ...

A new report finds Wisconsin's funding for childcare is 'untapped,' with more state-level options available to raise revenue than local ones.

Reported updated results from 12 patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led study ...

The Montana Department of Public Health and Human Services is projecting a budget shortfall of $34.4 million, staff told an ...

This research shows the fragility of both the nation’s retirement infrastructure and retirement preparedness for the typical ...

FedEx Corp. (NYSE: FDX) today reported the following consolidated results for the third quarter ended February 28 (adjusted measures exclude the items listed below): ...

Nvidia is no longer removing stock-based compensation expenses from its adjusted earnings per share calculation.

Increased ARR Leads to Higher Gross Margins and Adjusted EBITDAQ4 2025 revenue grew modestly to $5.8M compared to $5.7M ...

Positive Phase 3 topline results demonstrating envudeucitinib’s leading skin clearance, meaningful symptom improvement and a favorable safety profile in patients with moderate-to-severe plaque psorias ...